Stock

What the S&P 500, VIX, and ARKK are Telling Us Now

Read more
Stock

RRG Update: Is Tech Ready to Break Out?

Read more
Investing

HyProMag USA Receives “Make More in America” Domestic Finance Letter of Interest for up to US$92 Million From US EXIM Bank

Read more
Investing

Empire Metals Limited Announces Warrant Exercise

Read more
Investing

Juggernaut Files for Approval of Private Placement Financing

Read more
Investing

Harvest Gold Identifies 15 Primary And 10 Secondary Targets For Its Diamond Drill Program At Its Mosseau Project In Quebec

Read more
Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

You may also like

FireFly Metals to Add AU$95 Million to Coffers...

June 12, 2025

Harmony Gold to Acquire MAC Copper in US$1.03...

June 2, 2025

Rio Tinto Partners with Codelco to Develop Lithium...

May 23, 2025

Could the Silver Price Really Hit $100 per...

June 13, 2025

Triumph Gold Announces the Acquisition of the Coyote...

June 4, 2025

ARR advances permitting at Cowboy State Mine

May 28, 2025

Crypto Market Recap: Strategy Eyes US$1 Billion Capital...

June 7, 2025

Is Now a Good Time to Buy Bitcoin?

May 14, 2025

Crypto Market Recap: Bitcoin Price Hits New All-time...

May 22, 2025

Victoria Gold-Silver Exploration Update

June 5, 2025